Some studies show that low levels of PON-2 expression, due to its potent neuroprotective characteristics, impact various neurodegenerative diseases and conditions, such as AD, PD, ALS, and cerebral ischemia-reperfusion injuries [69,87,88,89]. This evidence concerns the gene PON2 and Alzheimer disease.